+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Diagnostic Radiopharmaceuticals for Alzheimer Disease Market - Global Forecast 2025-2030- Product Image
Diagnostic Radiopharmaceuticals for Alzheimer Disease Market - Global Forecast 2025-2030- Product Image
Sale

Diagnostic Radiopharmaceuticals for Alzheimer Disease Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082406
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Alzheimer’s diagnostic radiopharmaceuticals are redefining early disease detection and patient stratification, propelled by scientific advances and evolving regulatory frameworks. As this field matures, executives face decisions involving supply chain shifts, technology adoption, and global strategy alignment.

Alzheimer’s Diagnostic Radiopharmaceuticals: Market Snapshot

The global market for Alzheimer’s diagnostic radiopharmaceuticals benefits from rapid innovation in tracer chemistry and imaging hardware. Strategic partnerships between academic centers, diagnostic labs, and industry leaders fuel the translation of novel agents into clinical practice. Streamlined regulatory approvals have accelerated adoption, while distribution models adapt to new supply chain realities. Technology convergence and regional infrastructure development shape both competitive positioning and operational resilience.

Scope & Segmentation

This research report delivers in-depth analysis of market structure, growth dynamics, and opportunity mapping across pivotal segments and geographies. Decision-makers receive coverage of core segmentations and influential technologies:

  • Radiotracer Types: Carbon 11 Pittsburgh Compound B, Fluorine 18 Florbetaben, Fluorine 18 Florbetapir, Fluorine 18 Flutemetamol
  • Radioisotopes: Carbon 11, Fluorine 18
  • End Users: Diagnostic Centers, Hospitals, Research Laboratories
  • Applications: Clinical Imaging, Research Imaging
  • Distribution Channels: Direct Sales, Third Party Distribution
  • Key Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, South Africa, Saudi Arabia, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, and more)
  • Technologies Covered: Innovations in Carbon 11 and Fluorine 18 synthesis, advanced PET imaging systems, multimodal biomarker integration, digital supply chain platforms
  • Company Landscape: Major participants include Eli Lilly and Company, GE Healthcare Limited, Life Molecular Imaging, Bracco Imaging S.p.A., Fujifilm Holdings Corporation, Ion Beam Applications S.A., Curium Pharma, Navidea Biopharmaceuticals, and Avid Radiopharmaceuticals

Key Takeaways for Senior Decision-Makers

  • Innovations in tracer chemistry, such as next-generation Carbon 11 and Fluorine 18 agents, have set new standards for sensitivity and specificity in Alzheimer’s diagnostics.
  • Regional infrastructure and reimbursement variances create divergent adoption trajectories, with the Americas leading on clinical integration and emerging Asia-Pacific markets investing in domestic production and regulatory streamlining.
  • New manufacturing and distribution models are emerging as producers respond to tariff-driven cost increases and the need for decentralized cyclotron capabilities, especially for tracers with shorter half-lives.
  • Multi-sector collaborations are driving real-world evidence generation and optimizing clinical protocols, benefitting both commercial adoption and regulatory compliance.
  • Segment-specific priorities—rapid turnaround for diagnostic centers, workflow compatibility for hospitals, and protocol flexibility for research laboratories—are key to supplier differentiation.

Tariff Impact

In 2025, United States tariffs on precursor chemicals and specialized PET manufacturing equipment prompted a recalibration of cost structures. Radiopharmaceutical companies responded by localizing cyclotron facilities and automating synthesis modules to reduce exposure to supply chain vulnerabilities. Larger hospital networks have leveraged scale to cushion these impacts, while smaller laboratories accelerated regional production and explored collaborative procurement strategies. Ongoing adjustments to inventory management and customs regulations continue as stakeholders seek workflow stability.

Methodology & Data Sources

This report synthesizes secondary research from peer-reviewed literature, trial registries, and regulatory filings, augmented by structured interviews with radiochemists, imaging professionals, and supply chain leaders. Trend validation comes through triangulation with industry white papers and patent data, ensuring up-to-date, actionable insights for executive audiences.

Why This Report Matters

  • Delivers a strategic framework enabling executive teams to align product development, procurement, and global expansion efforts with evolving technological and regulatory dynamics.
  • Illuminates risks and opportunities related to supply chain shifts, regional market entries, and end-user priorities, equipping decision-makers to optimize resource allocation and go-to-market strategies.

Conclusion

Advancements in Alzheimer’s diagnostic radiopharmaceuticals demand adaptive strategy and agile execution. Senior leaders will benefit from expert-driven analysis to sustain operational resilience, foster innovation, and strengthen competitive positioning in this rapidly evolving diagnostic landscape.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of fluorine-18 labeled tracers for early detection of amyloid pathology in Alzheimer disease
5.2. Advancements in tau-specific radiotracers enhancing spatial resolution for precise neurodegeneration mapping
5.3. Collaborative clinical trials evaluating next-generation multivalent radiotracers for combined amyloid and tau imaging
5.4. Regulatory approvals accelerating commercialization of novel PET ligands targeting neuroinflammation markers
5.5. Integration of artificial intelligence algorithms for quantitative analysis of radiopharmaceutical imaging biomarkers in Alzheimer research
5.6. Emergence of cost-effective manufacturing processes for gallium-68 chelate radiopharmaceuticals supporting wider clinical adoption
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Diagnostic Radiopharmaceuticals for Alzheimer Disease Market, by Radiotracer Type
8.1. Introduction
8.2. Carbon 11 Pittsburgh Compound B
8.3. Fluorine 18 Florbetaben
8.4. Fluorine 18 Florbetapir
8.5. Fluorine 18 Flutemetamol
9. Diagnostic Radiopharmaceuticals for Alzheimer Disease Market, by Radioisotope
9.1. Introduction
9.2. Carbon 11
9.3. Fluorine 18
10. Diagnostic Radiopharmaceuticals for Alzheimer Disease Market, by End User
10.1. Introduction
10.2. Diagnostic Centers
10.3. Hospitals
10.4. Research Laboratories
11. Diagnostic Radiopharmaceuticals for Alzheimer Disease Market, by Application
11.1. Introduction
11.2. Clinical Imaging
11.3. Research Imaging
12. Diagnostic Radiopharmaceuticals for Alzheimer Disease Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Third Party Distribution
13. Americas Diagnostic Radiopharmaceuticals for Alzheimer Disease Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Diagnostic Radiopharmaceuticals for Alzheimer Disease Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Diagnostic Radiopharmaceuticals for Alzheimer Disease Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Eli Lilly and Company
16.3.2. GE Healthcare Limited
16.3.3. Life Molecular Imaging, Inc.
16.3.4. Bracco Imaging S.p.A.
16.3.5. Fujifilm Holdings Corporation
16.3.6. Ion Beam Applications S.A.
16.3.7. Curium Pharma, LLC
16.3.8. Navidea Biopharmaceuticals, Inc.
16.3.9. Avid Radiopharmaceuticals, Inc.
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET: RESEARCHAI
FIGURE 26. DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET: RESEARCHSTATISTICS
FIGURE 27. DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET: RESEARCHCONTACTS
FIGURE 28. DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY CARBON 11 PITTSBURGH COMPOUND B, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY CARBON 11 PITTSBURGH COMPOUND B, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY FLUORINE 18 FLORBETABEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY FLUORINE 18 FLORBETABEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY FLUORINE 18 FLORBETAPIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY FLUORINE 18 FLORBETAPIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY FLUORINE 18 FLUTEMETAMOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY FLUORINE 18 FLUTEMETAMOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY CARBON 11, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY CARBON 11, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY FLUORINE 18, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY FLUORINE 18, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY CLINICAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY CLINICAL IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RESEARCH IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RESEARCH IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY THIRD PARTY DISTRIBUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY THIRD PARTY DISTRIBUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 69. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 70. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 71. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 72. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 73. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 76. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 77. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 80. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 81. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 82. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 83. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 90. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 91. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 92. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 100. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 101. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 102. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 122. UNITED KINGDOM DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED KINGDOM DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. UNITED KINGDOM DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. GERMANY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 132. GERMANY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 133. GERMANY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 134. GERMANY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 135. GERMANY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. GERMANY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. GERMANY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. GERMANY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. GERMANY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. GERMANY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. FRANCE DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 142. FRANCE DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 143. FRANCE DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 144. FRANCE DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 145. FRANCE DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. FRANCE DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. FRANCE DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. FRANCE DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. FRANCE DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. FRANCE DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. RUSSIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 152. RUSSIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 153. RUSSIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 154. RUSSIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. RUSSIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. RUSSIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. ITALY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 162. ITALY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 163. ITALY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 164. ITALY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 165. ITALY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. ITALY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. ITALY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. ITALY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. ITALY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. ITALY DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. SPAIN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 172. SPAIN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 173. SPAIN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 174. SPAIN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 175. SPAIN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. SPAIN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. SPAIN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. SPAIN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. SPAIN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. SPAIN DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 192. SAUDI ARABIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 194. SAUDI ARABIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. SAUDI ARABIA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 202. SOUTH AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 204. SOUTH AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. SOUTH AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. DENMARK DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 212. DENMARK DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 213. DENMARK DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 214. DENMARK DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 215. DENMARK DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. DENMARK DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. DENMARK DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. DENMARK DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. DENMARK DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. DENMARK DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. NETHERLANDS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 222. NETHERLANDS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 223. NETHERLANDS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 224. NETHERLANDS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. NETHERLANDS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. NETHERLANDS DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. QATAR DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 232. QATAR DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 233. QATAR DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 234. QATAR DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 235. QATAR DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. QATAR DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. QATAR DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. QATAR DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. QATAR DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. QATAR DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. FINLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2018-2024 (USD MILLION)
TABLE 242. FINLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOTRACER TYPE, 2025-2030 (USD MILLION)
TABLE 243. FINLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2018-2024 (USD MILLION)
TABLE 244. FINLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY RADIOISOTOPE, 2025-2030 (USD MILLION)
TABLE 245. FINLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. FINLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. FINLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. FINLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. FINLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. FINLAND DIAGNOSTIC RADIOPHARMACEUTICALS FOR ALZHEIMER DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. SWEDEN DIAGNOSTIC

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Diagnostic Radiopharmaceuticals for Alzheimer Disease market report include:
  • Eli Lilly and Company
  • GE Healthcare Limited
  • Life Molecular Imaging, Inc.
  • Bracco Imaging S.p.A.
  • Fujifilm Holdings Corporation
  • Ion Beam Applications S.A.
  • Curium Pharma, LLC
  • Navidea Biopharmaceuticals, Inc.
  • Avid Radiopharmaceuticals, Inc.

Related Topics

Related Reports

Radiopharmaceuticals for Diagnosis Market - Global Forecast 2025-2030 - Product Image

Radiopharmaceuticals for Diagnosis Market - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Diagnostic Radiopharmaceuticals Market - Global Forecast 2025-2030 - Product Image

Diagnostic Radiopharmaceuticals Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Radiopharmaceuticals Market - Products and Applications - Product Image

Radiopharmaceuticals Market - Products and Applications

  • Report
  • 307 Pages
  • Global
From
Radiopharmaceuticals Market Growth Analysis Report - Market Size, Share, Forecast Trends and Outlook (2025-2034) - Product Image

Radiopharmaceuticals Market Growth Analysis Report - Market Size, Share, Forecast Trends and Outlook (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Single-Photon Emission Computed Tomography (SPECT): Market Share, and Growth Analysis by Product Type (System, Radiopharmaceuticals), Application, End User, Technology - Product Image

Single-Photon Emission Computed Tomography (SPECT): Market Share, and Growth Analysis by Product Type (System, Radiopharmaceuticals), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.